Stop making anaesthetic that killed 5, HP firm told

The Drugs Control Administration (DCA) has directed a pharmaceutical company at Kala Amb in Himachal’s Sirmaur district to stop manufacturing controversial injection Propofol following lab reports that it did not conform to the India Pharmacopoeia (IP) 2018 monograph nor met the quality standa

Related Keywords

India ,Kala Amb ,Himachal Pradesh ,Himachal Sirmaur ,Navneet Marwaha ,Garima Sharma ,Ambika Sharma ,Drugs Control Administration ,Regional Drug Testing Laboratory ,Kala Nixi Laboratories Private ,Central Drugs Standard Control Organisation ,India Pharmacopoeia ,Kala Amb Based Nixi Laboratories Private Limited ,Assistant Drug Controller Cum ,Cosmetics Act ,State Drugs Controller , ,